Retrospective Cohort Study
Copyright ©The Author(s) 2017.
World J Gastrointest Endosc. Sep 16, 2017; 9(9): 471-479
Published online Sep 16, 2017. doi: 10.4253/wjge.v9.i9.471
Table 1 Descriptive statistics of demographic and medication variables for patients receiving different analgesia/sedation regimes
VariableType of analgesia/sedation
Midazolam ± opioidEntonox ± opioidUnmedicated
Gender
Female (% of females)6753 (76.0%)1609 (18.1%)520 (5.9%)
Male (% of males)4613 (56.1%)2239 (27.2%)1373 (16.7%)
Median age/yr (IQR)61.1 (50.7-70.1)60.4 (50.8-69.1)63.8 (54.3-71.4)
Median midazolam dose/mg (IQR)2.5 (2.0-3.0)
Opioid, mcg
Number (%) given fentanyl10255 (90.2%)258 (6.7%)0 (0.0%)
Number (%) given pethidine1060 (9.3%)27 (0.7%)0 (0.0%)
Total number (%) given an opioid11299 (99.4%)284 (7.4%)0 (0.0%)
Median fentanyl equivalent dose (IQR)75.0 (50.0-100.0)75.0 (50.0-100.0)
Table 2 Moderate-to-extreme against none-mild discomfort by analgesia/sedation type
Variable1No. with moderate-to-extreme discomfort (%)2Odds ratio (95%CI)1P value1
Sedation type
Midazolam ± opioid2137 (18.8)Reference
Entonox ± opioid689 (17.9)1.06 (0.95-1.18)0.27
Unmedicated215 (11.4)0.71 (0.60-0.83)< 0.001
Age1.00 (1.00-1.01)0.08
Gender
Female2114 (23.9)Reference
Male927 (11.3)0.40 (0.36-0.43)< 0.001
Table 3 Caecal intubation for patients receiving different analgesia/sedation regimes
Variable1Caecal intubation rate, n (%)2Odds ratio (95%CI)1P value1
Sedation type
Midazolam ± opioid10562 (93.7)Reference
Entonox ± opioid3612 (94.4)1.08 (0.92-1.28)0.34
Unmedicated1763 (94.2)0.98 (0.79-1.22)0.87
Age0.98 (0.97-0.98)< 0.001
Gender
Female8159 (92.7)Reference
Male7778 (95.3)1.61 (1.41-1.85)< 0.001
Table 4 Polyp detection for patients receiving different analgesia/sedation regimes
Variable1Polyp detection rate, n (%)Odds ratio (95%CI)1P value1
Sedation type
Midazolam ± opioid3755 (33.1)Reference
Entonox ± opioid1345 (35.0)1.01 (0.93-1.10)0.79
Unmedicated707 (37.4)0.97 (0.87-1.08)0.6
Age1.03 (1.03-1.03)< 0.001
Gender
Female2454 (27.7)Reference
Male3353 (40.8)1.83 (1.71-1.96)< 0.001